Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 1, 2009, Pages 50-58

  Houiste, Céline ^a   Auguste, Cécile ^a   Macrez, Céline ^a   Dereux, Stéphanie ^a   Derouet, Angélique ^a   Anger, Pascal ^a  

^a SANOFI   (France)

Author keywords

Bovine; Contamination; Disaccharide; HIT; Immunologic; Low molecular weight heparins (LMWHs); Ovine; Porcine; Quantitative PCR (Q PCR)

Indexed keywords

DISACCHARIDE; DNA; ENOXAPARIN; GENOMIC DNA; HEPARIN; HEPARIN LYASE; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; COW; DEPOLYMERIZATION; DRUG CONTAMINATION; DRUG PURIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY ANALYSIS; SHEEP; SWINE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISACCHARIDES; DNA; HEPARIN, LOW-MOLECULAR-WEIGHT; POLYMERASE CHAIN REACTION; SWINE;

EID: 58449115158     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608320831     Document Type: Article

References (25)

1. Mousa SA The low molecular weight heparin, tinzaparin, in thrombosis and beyond. Cardiovasc Drug Rev. 2002 ; 20: 199-216.
2. Hillerton JE Bovine spongiform encephalopathy: current status and possible impacts. J Dairy Sci. 1998 ; 81: 3042-3048.
3. Bell WR, Royall RM Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med. 1980 ; 303: 902-907.
4. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci. 1993 ; 305: 208-215.
5. Francis JL, Palmer GJ 3rd, Moroose R., Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg. 2003 ; 75: 17-22.
6. European Directorate for the Quality of Medicines and HealthCare. European Pharmacopoeia monograph 1097, supplement 6.0. http://www.edqm.eu. Accessed March 2008.
7. U.S. Pharmacopeia. USP NF. http://www.usp.org. Accessed March 2008.
8. Guerrini M., Guglieri S., Naggi A., Sasisekharan R., Torri G. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost. 2007 ; 33: 478-487.
9. Aventis Pharmaceuticals Inc. Citizen petition supplement n°3, 03P-0064. 2006.
10. Saad OM, Leary JA Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool. Anal Chem. 2005 ; 77: 5902-5911.
11. Mourier P., Viskov C. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cethyltrimethylammonium dynamically coated stationary phases. Anal Biochem. 2004 ; 332: 299-313.
12. Pervin A., Gallo C., Jandik KA, Han XJ, Linhardt RJ Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology. 1995 ; 5: 83-95.
13. Huang Q., Yao CY, Chen B., Wang F., Huang JF, Zhang X., Fu WL Species-specific identification by inhibitor-controlled PCR of ruminant components contaminating industrial crude porcine heparin. Mol Cell Probes. 2006 ; 20: 250-258.
14. Camara JE, Satterfield MB, Nelson BC Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry. J Pharm Biomed Anal. 2007 ; 43: 1706-1714.
15. Rice KG, Kim YS, Grant AC, Merchant ZM, Linhardt RJ High-performance liquid chromatographic separation of heparin-derived oligosaccharides. Anal Biochem. 1985 ; 150: 325-331.
16. Ruiz-Calero V., Moyano E., Puignou L., Galceran M. Pressure-assisted capillary electrophoresis-electrospray ion trap mass spectrometry for the analysis of heparin depolymerised disaccharides. J Chromatogr A. 2001 ; 914: 277-291.
17. Kinoshita A., Sugahara K. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal Biochem. 1999 ; 269: 367-378.
18. Hartmann LJ, Coyne SR, Norwood DA Development of a novel internal positive control for Taqman based assays. Mol Cell Probes. 2005 ; 19: 51-59.
19. Al-Soud WA, Rådström P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol. 2001 ; 39: 485-493.
20. Abu Al-Soud W., Rådström P. Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces, and meat. J Clin Microbiol. 2000 ; 38: 4463-4470.
21. Al-Soud WA, Ouis IS, Li DQ, Ljungh A., Wadström T. Characterization of the PCR inhibitory effect of bile to optimize real-time PCR detection of Helicobacter species. FEMS Immunol Med Microbiol. 2005 ; 44: 177-182.
22. Tsai M., Miyamoto M., Tam SY, Wang ZS, Galli SJ Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol. 1995 ; 146: 335-343.
23. Ruiz-Calero V., Saurina J., Galceran MT, Hernández-Cassou S., Puignou L. Estimation of the composition of heparin mixtures from various origins using proton nuclear magnetic resonance and multivariate calibration methods. Anal Bioanal Chem. 2002 ; 373: 259-265.
24. Bianchini P., Liverani L., Mascellani G., Parma B. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes. Semin Thromb Hemost. 1997 ; 23: 3-10.
25. Massart DL et al. Chapter 31: analysis of measurement tables. In: Massart DL, Vandeginste BGM, Buydens LMC, De Jong S, Lewi PJ, Smeyers-Verbeke J, eds. Data Handling in Science and Technology, 20B. Handbook of Chemometrics and Qualimetrics: Part B. Amsterdam: Elsevier Science; 1998: 88-158.